drugset / Trial / NCT02467634

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

NCT02467634

Phase 2 Terminated 3 enrolled StemCells, Inc.
NaSingle-groupOpen-labelTreatment

Summary

A fellow eye controlled study of HUCNS-SC sub-retinal transplantation in subjects with bilateral GA AMD. All subjects will be assigned to HUCNS-SC transplantation.

Timeline

Start
2015-06
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rexlemestrocel-L Cell therapy Other